Metropolis Healthcare Limited (METROPOLIS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.091x

Based on the latest financial reports, Metropolis Healthcare Limited (METROPOLIS) has a cash flow conversion efficiency ratio of 0.091x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.32 Billion ≈ $14.25 Million USD) by net assets (Rs14.43 Billion ≈ $156.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see METROPOLIS company net worth for the company's overall valuation and market capitalisation.

Metropolis Healthcare Limited - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Metropolis Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Metropolis Healthcare Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Metropolis Healthcare Limited ranked by their cash flow conversion efficiency. Explore how high is Metropolis Healthcare Limited's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Jiangxi Everbright Measurement Cont SHE:300906	0.007x
Top Gum Industries Ltd TA:TPGM	0.020x
Viemed Healthcare Inc NASDAQ:VMD	0.136x
Tungsten Mining NL AU:TGN	-0.091x
MVB Financial Corp NASDAQ:MVBF	-0.070x
Yulie Sekurindo Tbk JK:YULE	-0.032x
Honey Hope Honesty Enterprise Co Ltd TWO:8043	-0.009x
Bredband2 i Skandinavien AB ST:BRE2	0.127x

Annual Cash Flow Conversion Efficiency for Metropolis Healthcare Limited (2014–2025)

The table below shows the annual cash flow conversion efficiency of Metropolis Healthcare Limited from 2014 to 2025. View METROPOLIS share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs13.35 Billion ≈ $144.34 Million	Rs2.63 Billion ≈ $28.41 Million	0.197x	-18.05%
2024-03-31	Rs10.99 Billion ≈ $118.88 Million	Rs2.64 Billion ≈ $28.56 Million	0.240x	-3.68%
2023-03-31	Rs9.91 Billion ≈ $107.14 Million	Rs2.47 Billion ≈ $26.72 Million	0.249x	-12.54%
2022-03-31	Rs8.88 Billion ≈ $96.05 Million	Rs2.53 Billion ≈ $27.39 Million	0.285x	-18.92%
2021-03-31	Rs7.08 Billion ≈ $76.57 Million	Rs2.49 Billion ≈ $26.93 Million	0.352x	-14.09%
2020-03-31	Rs5.25 Billion ≈ $56.79 Million	Rs2.15 Billion ≈ $23.25 Million	0.409x	+90.72%
2019-03-31	Rs4.20 Billion ≈ $45.42 Million	Rs901.51 Million ≈ $9.75 Million	0.215x	-11.37%
2018-03-31	Rs4.29 Billion ≈ $46.41 Million	Rs1.04 Billion ≈ $11.24 Million	0.242x	-18.09%
2017-03-31	Rs3.44 Billion ≈ $37.22 Million	Rs1.02 Billion ≈ $11.00 Million	0.296x	-4.95%
2016-03-31	Rs2.94 Billion ≈ $31.78 Million	Rs914.16 Million ≈ $9.89 Million	0.311x	+72.03%
2015-03-31	Rs3.84 Billion ≈ $41.56 Million	Rs694.91 Million ≈ $7.52 Million	0.181x	-25.29%
2014-03-31	Rs3.18 Billion ≈ $34.37 Million	Rs769.22 Million ≈ $8.32 Million	0.242x	--

About Metropolis Healthcare Limited

NSE:METROPOLIS India Diagnostics & Research

Market Cap

$334.90 Million

Rs30.97 Billion INR

Market Cap Rank

#14412 Global

#723 in India

Share Price

Rs597.45

Change (1 day)

+1.90%

52-Week Range

Rs421.75 - Rs2107.40

All Time High

Rs3431.71